Previous studies show that TTN mutation is related to high immunogenicity and inflammatory tumor immune microenvironment in lung adenocarcinoma, accompanied by favorable objective response and survival with ICI administration [51, 52]. The gene discussed is TTN; the disease is neoplasm.